• Every dose printed on the panel
  • Prices shown per serving
  • Cautions printed on the page
  • 30-day money-back guarantee
Which routine is right for you?See your routine

Research review

Does berberine help with cancer? What the research does and doesn't show

The one substantial human trial tested berberine against the recurrence of precancerous colon polyps after removal, at 600 mg a day — not against cancer itself, and no cancers occurred in either study group.

By Electric Tiger Editorial

The evidence doesn't support berberine as a cancer treatment or a way to prevent cancer. The one substantial human trial tested it against the recurrence of precancerous colon polyps after they'd already been removed — not against cancer itself — at 600 mg a day, and no colorectal cancers occurred in either study group.

What the evidence doesn't support

It doesn't support berberine treating an existing cancer, shrinking a tumor, or being taken to prevent cancer in a general population. It doesn't support anything about berberine and estrogen-positive breast cancer specifically — no human trial has tested that pairing. And "cancer stem cells" is a laboratory concept studied in cell cultures, not something measured in a person; nothing here should be read as evidence about how berberine behaves in a person with cancer.

What the trials found

The main human evidence is a 2020 randomized, placebo-controlled trial in The Lancet Gastroenterology & Hepatology: 1,108 adults across seven hospitals in China who'd already had one to six colorectal adenomas (a type of polyp that can turn into cancer over years) removed were assigned to berberine, 300 mg twice a day, or placebo for up to two years. Adenomas recurred in 36% of the berberine group versus 47% of the placebo group (relative risk 0.77, p=0.001). No colorectal cancers were detected in either group during the study — the trial wasn't designed or large enough to test berberine against actual cancer occurrence, only against polyp recurrence. The most common side effect was constipation, reported by about 1% of the berberine group versus under 0.5% on placebo.

A 2025 follow-up of the same trial's participants, six years after they'd stopped taking berberine, found the lower recurrence rate had persisted: 34.7% of the original berberine group had a recurrent adenoma versus 52.1% of the original placebo group, and any new growth (neoplasm) occurred in 63.4% versus 71.0%. That's a real, sustained difference in polyp recurrence after treatment stopped — but it's still a finding about precancerous polyps in people who'd already had one removed, at 600 mg a day, not a finding about treating or preventing cancer.

Questions people ask

Does berberine help with cancer?

No trial has tested berberine against an existing cancer. The trial evidence above is about preventing the recurrence of precancerous colon polyps in people who'd already had one removed — a narrower and different question.

Is berberine good for estrogen-positive breast cancer?

There's no human trial on berberine and breast cancer of any type. Any claim connecting the two comes from laboratory research, not a study in people.

What does the "berberine cancer warning" refer to?

If you've seen a warning framed that way, it likely isn't describing the trial above — that trial's only notable side effect was constipation, and no cancer cases occurred in either group. Berberine does carry real cautions around pregnancy, drug interactions and dosing; see who should not take berberine for what's actually documented.

What are berberine and cancer stem cells?

That's a line of laboratory research looking at how berberine affects cancer cells in a dish, including a subpopulation called cancer stem cells. It hasn't been tested in people and doesn't tell you what berberine does in a person's body.

When to talk to a doctor

Berberine is not a treatment for cancer, and nothing in the trial evidence above supports using it to prevent, treat or replace medical care for cancer of any kind. Anyone with a cancer diagnosis, a history of colorectal polyps, or a family history of colorectal cancer should follow their doctor's screening and treatment plan; a supplement is not part of that plan. Anyone taking a prescription medication, or who is pregnant or nursing, should also check with a doctor before starting berberine.

Related reading: who should not take berberine, berberine side effects, and berberine: what the research does and doesn't show.

Sources

  1. Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study The lancet. Gastroenterology & hepatology · 2020 · PMID 31926918In adults who'd had precancerous colon polyps removed, 600 mg of berberine a day for up to two years lowered the rate of new polyps compared with placebo; no cancers occurred in either group.
  2. Berberine for preventing colorectal adenoma recurrence and neoplasm occurrence: 6-Year follow-up of a randomized clinical trial Cell reports. Medicine · 2025 · PMID 40795846Six years after stopping a two-year course of berberine, people originally assigned to berberine still had a lower rate of colon-polyp recurrence than those originally assigned to placebo.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.